Stamford Pharmaceuticals announced receiving HREC approval for the commencement of the initial phase of its registration program

Stamford Pharmaceuticals announced today receiving ethics approval for the Pilot phase of its registration program. The program will commence initially at Australian sites with US sites for the program planned for initiation in 2020.
Press Release: SP HREC Approval